Kreatech.eu
About Kreatech.eu
Kreatech.eu is a Healthcare company, and was acquired by Leica Biosystems in July 2013. FISH probes are developed for detecting genetic aberrations. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Probes and Dyes.
Company details
DNA-FISH probes are developed by Kreatech.eu to identify genetic aberrations in clinical applications. A range of probes, including REPEAT-FREE and POSEIDON variants, is maintained for targeting specific genes and tumors in bone and soft tissue samples. Operations center on molecular diagnostics within the biotechnology sector, with products supplied commercially to support research and pathology workflows.
- Stage Acquired
- SectorsHealthcare
- Website kreatech.eu
- Acquired by Leica Biosystems (Jul 2013)
- Investors
- Acquired byLeica Biosystems
(Jul 2013)
Investors in Kreatech.eu
Kreatech.eu has secured backing from 1 investor. Prominent investors backing the company include Leica Biosystems.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provides tools for anatomic pathology, histology, and digital cancer diagnostics worldwide. | 1989 | leicabiosystems.com | Nussloch, Germany |
Investor details for Kreatech.eu
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kreatech.eu
DNA-FISH probes are developed by Kreatech.eu to identify genetic aberrations in clinical applications. A range of probes, including REPEAT-FREE and POSEIDON variants, is maintained for targeting specific genes and tumors in bone and soft tissue samples. Operations center on molecular diagnostics within the biotechnology sector, with products supplied commercially to support research and pathology workflows.
Kreatech.eu has 1 investor. Key investors include Leica Biosystems.
Yes. Kreatech.eu was acquired by Leica Biosystems in July 2013.